131 related articles for article (PubMed ID: 33522823)
41. Antitumor and chemosensitizing action of dichloroacetate implicates modulation of tumor microenvironment: a role of reorganized glucose metabolism, cell survival regulation and macrophage differentiation.
Kumar A; Kant S; Singh SM
Toxicol Appl Pharmacol; 2013 Nov; 273(1):196-208. PubMed ID: 24051182
[TBL] [Abstract][Full Text] [Related]
42. Therapeutic Targeting of MicroRNAs in the Tumor Microenvironment.
Raue R; Frank AC; Syed SN; Brüne B
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672261
[TBL] [Abstract][Full Text] [Related]
43. Chemotherapeutic drug delivery to cancer cells using a combination of folate targeting and tumor microenvironment-sensitive polypeptides.
Gao W; Xiang B; Meng TT; Liu F; Qi XR
Biomaterials; 2013 May; 34(16):4137-4149. PubMed ID: 23453200
[TBL] [Abstract][Full Text] [Related]
44. Interferon-γ and celecoxib inhibit lung-tumor growth through modulating M2/M1 macrophage ratio in the tumor microenvironment.
Ren F; Fan M; Mei J; Wu Y; Liu C; Pu Q; You Z; Liu L
Drug Des Devel Ther; 2014; 8():1527-38. PubMed ID: 25284985
[TBL] [Abstract][Full Text] [Related]
45. Targeting microRNAs as key modulators of tumor immune response.
Paladini L; Fabris L; Bottai G; Raschioni C; Calin GA; Santarpia L
J Exp Clin Cancer Res; 2016 Jun; 35():103. PubMed ID: 27349385
[TBL] [Abstract][Full Text] [Related]
46. Multifunctional Nanoparticles Boost Cancer Immunotherapy Based on Modulating the Immunosuppressive Tumor Microenvironment.
Li J; Zhao M; Sun M; Wu S; Zhang H; Dai Y; Wang D
ACS Appl Mater Interfaces; 2020 Nov; 12(45):50734-50747. PubMed ID: 33124808
[TBL] [Abstract][Full Text] [Related]
47. A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells.
Png KJ; Halberg N; Yoshida M; Tavazoie SF
Nature; 2011 Dec; 481(7380):190-4. PubMed ID: 22170610
[TBL] [Abstract][Full Text] [Related]
48. Targeted and intracellular triggered delivery of therapeutics to cancer cells and the tumor microenvironment: impact on the treatment of breast cancer.
Moura V; Lacerda M; Figueiredo P; Corvo ML; Cruz ME; Soares R; de Lima MC; Simões S; Moreira JN
Breast Cancer Res Treat; 2012 May; 133(1):61-73. PubMed ID: 21805188
[TBL] [Abstract][Full Text] [Related]
49. A surface charge-switchable and folate modified system for co-delivery of proapoptosis peptide and p53 plasmid in cancer therapy.
Chen S; Rong L; Lei Q; Cao PX; Qin SY; Zheng DW; Jia HZ; Zhu JY; Cheng SX; Zhuo RX; Zhang XZ
Biomaterials; 2016 Jan; 77():149-63. PubMed ID: 26599622
[TBL] [Abstract][Full Text] [Related]
50. The active fraction of Garcinia yunnanensis suppresses the progression of colorectal carcinoma by interfering with tumorassociated macrophage-associated M2 macrophage polarization in vivo and in vitro.
Sui H; Tan H; Fu J; Song Q; Jia R; Han L; Lv Y; Zhang H; Zheng D; Dong L; Wang S; Li Q; Xu H
FASEB J; 2020 Jun; 34(6):7387-7403. PubMed ID: 32283574
[TBL] [Abstract][Full Text] [Related]
51. Fabrication of dual responsive co-delivery system based on three-armed peptides for tumor therapy.
Chen S; Lei Q; Li SY; Qin SY; Jia HZ; Cheng YJ; Zhang XZ
Biomaterials; 2016 Jun; 92():25-35. PubMed ID: 27031930
[TBL] [Abstract][Full Text] [Related]
52. Drug-free mannosylated liposomes inhibit tumor growth by promoting the polarization of tumor-associated macrophages.
Ye J; Yang Y; Dong W; Gao Y; Meng Y; Wang H; Li L; Jin J; Ji M; Xia X; Chen X; Jin Y; Liu Y
Int J Nanomedicine; 2019; 14():3203-3220. PubMed ID: 31118632
[No Abstract] [Full Text] [Related]
53. An innovative NRF2 nano-modulator induces lung cancer ferroptosis and elicits an immunostimulatory tumor microenvironment.
Hsieh CH; Hsieh HC; Shih FS; Wang PW; Yang LX; Shieh DB; Wang YC
Theranostics; 2021; 11(14):7072-7091. PubMed ID: 34093872
[TBL] [Abstract][Full Text] [Related]
54. Dual-function synthetic peptide derived from BMP4 for highly efficient tumor targeting and antiangiogenesis.
Choi SH; Lee JY; Suh JS; Park YS; Chung CP; Park YJ
Int J Nanomedicine; 2016; 11():4643-4656. PubMed ID: 27695323
[TBL] [Abstract][Full Text] [Related]
55. Tasquinimod inhibits prostate cancer growth in bone through alterations in the bone microenvironment.
Magnusson LU; Hagberg Thulin M; Plas P; Olsson A; Damber JE; Welén K
Prostate; 2016 Mar; 76(4):383-93. PubMed ID: 26660725
[TBL] [Abstract][Full Text] [Related]
56. Potential applications of nanoparticles for tumor microenvironment remodeling to ameliorate cancer immunotherapy.
Bai Y; Wang Y; Zhang X; Fu J; Xing X; Wang C; Gao L; Liu Y; Shi L
Int J Pharm; 2019 Oct; 570():118636. PubMed ID: 31446027
[TBL] [Abstract][Full Text] [Related]
57. Silencing of long noncoding RNA LEF1-AS1 prevents the progression of hepatocellular carcinoma via the crosstalk with microRNA-136-5p/WNK1.
Dong H; Jian P; Yu M; Wang L
J Cell Physiol; 2020 Oct; 235(10):6548-6562. PubMed ID: 32068261
[TBL] [Abstract][Full Text] [Related]
58. Antitumor immunity is defective in T cell-specific microRNA-155-deficient mice and is rescued by immune checkpoint blockade.
Huffaker TB; Lee SH; Tang WW; Wallace JA; Alexander M; Runtsch MC; Larsen DK; Thompson J; Ramstead AG; Voth WP; Hu R; Round JL; Williams MA; O'Connell RM
J Biol Chem; 2017 Nov; 292(45):18530-18541. PubMed ID: 28912267
[TBL] [Abstract][Full Text] [Related]
59. Extracts of Cordyceps sinensis inhibit breast cancer growth through promoting M1 macrophage polarization via NF-κB pathway activation.
Li J; Cai H; Sun H; Qu J; Zhao B; Hu X; Li W; Qian Z; Yu X; Kang F; Wang W; Zou Z; Gu B; Xu K
J Ethnopharmacol; 2020 Oct; 260():112969. PubMed ID: 32422358
[TBL] [Abstract][Full Text] [Related]
60. Catecholamines contribute to the neovascularization of lung cancer via tumor-associated macrophages.
Xia Y; Wei Y; Li ZY; Cai XY; Zhang LL; Dong XR; Zhang S; Zhang RG; Meng R; Zhu F; Wu G
Brain Behav Immun; 2019 Oct; 81():111-121. PubMed ID: 31176001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
